| Literature DB >> 31955618 |
Ichiro Kobayashi1, Shinji Akioka2, Norimoto Kobayashi3, Naomi Iwata4, Shunichiro Takezaki5, Haruna Nakaseko4, Satoshi Sato6, Yutaka Nishida7, Tomo Nozawa8, Yuichi Yamasaki9, Kazuko Yamazaki10, Satoru Arai11, Ichizo Nishino12, Masaaki Mori13.
Abstract
Juvenile dermatomyositis is the most common type of juvenile idiopathic inflammatory myopathy mainly affecting the skin and proximal muscles. We have published the Japanese version of 'Clinical practice guidance for juvenile dermatomyositis (JDM) 2018 'consisting of a review of articles in the field and evidence-informed consensus-based experts' opinion on the treatment strategy in collaboration with The Pediatric Rheumatology Association of Japan and The Japan College of Rheumatology under the financial support by 'Research on rare and intractable diseases, Health and Labor Sciences Research Grants'. This article is a digest version of the Japanese guidance.Entities:
Keywords: Diagnosis; interstitial lung disease; management; myositis-specific autoantibodies; pathophysiology
Year: 2020 PMID： 31955618 DOI： 10.1080/14397595.2020.1718866
Source DB: PubMed Journal: Mod Rheumatol ISSN： 1439-7595 Impact factor: 3.023